Joensuu, Heikki <br/><br/>
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.  [electronic resource] 

 -  JAMA oncology  May 2017 
 - 602-609 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2016.5751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Chemotherapy, Adjuvant<br/>DNA Mutational Analysis--methods<br/>DNA, Neoplasm--genetics<br/>Drug Administration Schedule<br/>Female<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Mutation<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Receptor, Platelet-Derived Growth Factor alpha--genetics